Impact of Port-A-Cath device management in cancer patients with candidaemia

Y. C. Lai, L. J. Huang, T. L. Chen, Y. W. Yang, L. T. Hsiao, H. W. Teng, C. P. Fung, T. J. Chiou, C. H. Tzeng, C. Y. Liu

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)


This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3-4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock.

頁(從 - 到)281-285
期刊Journal of Hospital Infection
出版狀態已發佈 - 十二月 2012

ASJC Scopus subject areas

  • 微生物學(醫學)
  • 傳染性疾病


深入研究「Impact of Port-A-Cath device management in cancer patients with candidaemia」主題。共同形成了獨特的指紋。